BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12736006)

  • 21. Laparoscopic treatment of renal cancer in children: a multicentric study and review of oncologic and surgical complications.
    Varlet F; Petit T; Leclair MD; Lardy H; Geiss S; Becmeur F; Ravasse P; Rod J; de Lambert G; Braik K; Lardellier-Reynaud F; Lopez M
    J Pediatr Urol; 2014 Jun; 10(3):500-5. PubMed ID: 24332932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radical nephrectomy is still preferable in the treatment of localized renal cell carcinoma. A long-term follow-up study.
    Ljungberg B; Alamdari FI; Holmberg G; Granfors T; Duchek M
    Eur Urol; 1998; 33(1):79-85. PubMed ID: 9471045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Conservative surgery for renal carcinoma].
    González Martín M; Alvarez Castelo LM; Chantada Abal V; Rodríguez-Rivera J; Sánchez Merino JM; Gómez Veiga F
    Actas Urol Esp; 1999 May; 23(5):424-31. PubMed ID: 10427817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
    La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A
    J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery.
    Butler BP; Novick AC; Miller DP; Campbell SA; Licht MR
    Urology; 1995 Jan; 45(1):34-40; discussion 40-1. PubMed ID: 7817478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience with fossa recurrence of renal cell carcinoma.
    Esrig D; Ahlering TE; Lieskovsky G; Skinner DG
    J Urol; 1992 Jun; 147(6):1491-4. PubMed ID: 1593672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laparoscopic resection of isolated fossa recurrence of renal cell carcinoma after open nephrectomy: report of 6 cases and literature review.
    Vitagliano G; Ameri C; Castillo O; Rozanec J
    Arch Esp Urol; 2014 Apr; 67(3):277-83. PubMed ID: 24840593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
    Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
    J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system.
    Belldegrun A; Tsui KH; deKernion JB; Smith RB
    J Clin Oncol; 1999 Sep; 17(9):2868-75. PubMed ID: 10561364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative external beam radiotherapy followed by cytoreductive surgery and intraoperative radiotherapy for locally advanced primary or recurrent renal malignancies.
    Frydenberg M; Gunderson L; Hahn G; Fieck J; Zincke H
    J Urol; 1994 Jul; 152(1):15-21. PubMed ID: 8201647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a Postoperative Nomogram Predicting Recurrence in Patients with Conventional Clear Cell Renal Cell Carcinoma.
    Lee BH; Feifer A; Feuerstein MA; Benfante NE; Kou L; Yu C; Kattan MW; Russo P
    Eur Urol Focus; 2018 Jan; 4(1):100-105. PubMed ID: 28753780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a.
    Shah PH; Moreira DM; Patel VR; Gaunay G; George AK; Alom M; Kozel Z; Yaskiv O; Hall SJ; Schwartz MJ; Vira MA; Richstone L; Kavoussi LR
    J Urol; 2017 Aug; 198(2):289-296. PubMed ID: 28274620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Jonasch E; Merchant MM; Spiess PE; Wood CG
    Urology; 2007 May; 69(5):835-8. PubMed ID: 17482917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery.
    Ishimura T; Sakai I; Hara I; Eto H; Miyake H
    Int J Urol; 2004 May; 11(5):264-8. PubMed ID: 15147540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility and oncological outcomes of laparoscopic treatment for local relapse of renal cell carcinoma.
    El Hajj A; Thanigasalam R; Molinié V; Massoud W; Fourati M; Girard F; Escudier B; Baumert H
    BJU Int; 2013 Aug; 112(4):E307-13. PubMed ID: 23551636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resection of recurrent inferior vena cava tumor after radical nephrectomy for renal cell carcinoma.
    Smaldone MC; Cannon GM; Hrebinko RL
    Urology; 2006 May; 67(5):1084.e5-7. PubMed ID: 16698379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensive Imaging-based Follow-up of Surgically Treated Localised Renal Cell Carcinoma Does Not Improve Post-recurrence Survival: Results from a European Multicentre Database (RECUR).
    Dabestani S; Beisland C; Stewart GD; Bensalah K; Gudmundsson E; Lam TB; Gietzmann W; Zakikhani P; Marconi L; Fernandéz-Pello S; Monagas S; Williams SP; Torbrand C; Powles T; Van Werkhoven E; Meijer R; Volpe A; Staehler M; Ljungberg B; Bex A
    Eur Urol; 2019 Feb; 75(2):261-264. PubMed ID: 30318330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expanding indications for conservative renal surgery in renal cell carcinoma.
    Thrasher JB; Robertson JE; Paulson DF
    Urology; 1994 Feb; 43(2):160-8. PubMed ID: 8116109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conservative surgery of renal cell tumors in 140 patients: 21 years of experience.
    Steinbach F; Stöckle M; Müller SC; Thüroff JW; Melchior SW; Stein R; Hohenfellner R
    J Urol; 1992 Jul; 148(1):24-9; discussion 29-30. PubMed ID: 1613874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.